Shandong Luning Pharmaceutical Co., Ltd.

CN EN

Shandong Luning Pharmaceutical Co., Ltd.

NEWS CENTER

Taking care of human life with heart and continuously improving healthy life

Scroll loading

Your location:

Homepage

NEWS

Luning Pharmaceutical's LN020II Phase Clinical Launch Meeting and National Researcher Conference were grandly held

On March 15th, the kickoff meeting for the Phase II clinical trial of LN020, a Class 1 anti influenza drug independently developed by Luning Pharmaceutical, and the National Researchers Conference were held in Chongqing.

28 2025/04

Luning Pharmaceutical's LN020II Phase Clinical Launch Meeting and National Researcher Conference were grandly held

Innovation Empowers and Deepens Cooperation —— Academician Yan Deyue of the Chinese Academy of Sciences Pays a Visit for Exchanges

On August 25, a delegation led by Yan Deyue, an academician of the CAS Member, a professor and doctoral supervisor of the School of Chemical Engineering of Shanghai Jiaotong University, visited and carried out work exchanges.

28 2025/04

Innovation Empowers and Deepens Cooperation —— Academician Yan Deyue of the Chinese Academy of Sciences Pays a Visit for Exchanges

Luning Pharmaceutical conducts comprehensive emergency rescue drills.

On May 5, 2024, the company organized a comprehensive emergency rescue drill for all personnel. The purpose of this drill is to strengthen employees' awareness of safety production

28 2025/04